How effective is Tecfidera for Relapsing-remitting Multiple Sclerosis? (a real world drug study)
Summary:
Overall ratings: 3.1/5 Long term ratings: 3.4/5
This is a phase IV clinical study of how effective Tecfidera (dimethyl fumarate) is for Relapsing-remitting multiple sclerosis and for what kind of people. The study is created by eHealthMe from 13 Tecfidera users and is updated continuously.
What is Tecfidera?
Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.
What is Relapsing-remitting multiple sclerosis?
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 127 drugs and 177 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.
13 people are studied for taking Tecfidera in Relapsing-remitting multiple sclerosis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Tecfidera effectiveness for Relapsing-remitting multiple sclerosis (number of people):
Overall:
- not at all: 2
- somewhat: 2
- moderate: 4
- high: 3
- very high: 2
Long Term:
- not at all: 1
- somewhat: 0
- moderate: 1
- high: 2
- very high: 1
Gender of people who take Tecfidera for Relapsing-remitting multiple sclerosis *:
- female: 92.31 %
- male: 7.69 %
Age of people who take Tecfidera for Relapsing-remitting multiple sclerosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 7.69 %
- 30-39: 38.46 %
- 40-49: 23.08 %
- 50-59: 23.08 %
- 60+: 7.69 %
Who find Tecfidera more effective for Relapsing-remitting Multiple Sclerosis?
Gender of people who take Tecfidera for Relapsing-remitting multiple sclerosis *:
- female: 80 %
- male: 20 %
Age of people who take Tecfidera for Relapsing-remitting multiple sclerosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 20 %
- 40-49: 20 %
- 50-59: 40 %
- 60+: 20 %
* Approximation only. Some reports may have incomplete information.
Do you take Tecfidera?
- You can start a phase IV clinical trial to monitor Tecfidera safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Tecfidera (129,627 reports)
Treatments, associated drugs and conditions:
- Relapsing-remitting multiple sclerosis (76,275 reports)
How the study uses the data?
The study is based on dimethyl fumarate (the active ingredients of Tecfidera) and Tecfidera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Pantoprazole Sodium and Phentermine - now
- Drug interactions of Mavik and Clonazepam - 3 seconds ago
- Could Ciprofloxacin cause Local Swelling? - 10 seconds ago
- Could Cephalexin cause Hoarseness Or Changing Voice? - 40 seconds ago
- Diphen vs. Unisom, side effect and effectiveness comparison - a minute ago
- Maternal Therapy To Enhance Foetal Lung Maturity and Face Oedema - a minute ago
- Could Prempro cause Haemorrhoids Aggravated? - a minute ago
- How effective is Alendronic Acid for Osteoporosis? - a minute ago
- Could Milk Thistle cause Seizures? - a minute ago
- Could Zoloft cause Herpes Zoster? - a minute ago